AFAkihiro Funakoshi

Akihiro Funakoshi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Akihiro Funakoshi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Kyoko Miyasaka

    Department of Clinical Physiology, Tokyo Metropolitan Institute of Gerontology, Tokyo 173-0015, Japan

    2 shared publications
  • Akira Kono

    Department of Chemotherapy, National Kyushu Cancer Center, Fukuoka 811-1395, Japan

    1 shared publication
  • Ayako Sekime

    Department of Clinical Physiology, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakaecho Itabashiku 173-0015, Tokyo, Japan

    1 shared publication
  • Hideo Matsumoto

    Department of Cellular Genetics, Mitsubishi Kagaku Bio-Clinical Laboratories, INC, Tokyo 174-8555, Japan

    1 shared publication
  • Hiroshi Shimokata

    Department of Epidemiology, National Institute for Longevity Sciences, Ohbu 474-8522, Japan

    1 shared publication
  • Kazuhiro Kataoka

    Department of Chemotherapy, National Kyushu Cancer Center, Fukuoka 811-1395, Japan

    1 shared publication

Latest Publications

  • Open Access

    Susceptibility to obesity and gallbladder stasis produced by a protein- and fat-enriched diet in male mice compared with female mice

    by Kyoko Miyasaka, Setsuko Kanai, Minoru Ohta, Ayako Sekime, Saeko Akimoto, Soichi Takiguchi, Akihiro Funakoshi

    The frequency of Japanese subjects over 20 years old with metabolic syndrome is 45.6% in men but just 16.7% in women. The reason why Japanese male subjects are more susceptible to metabolic syndrome than women is unknown. One possibility is the higher frequency of Japanese male subjects (40–70 years old) who had a drinking habit (67%), while that of female subjects was only 25%. In addition, daily fat intake was markedly increased in Japanese subjects (from 9% to 25%), and cholesterol cholelithiasis is one of the most rapidly increasing digestive diseases during the past 50 years. The object of this study is to examine whether a potential sex-related risk factor exists in the manifestation of metabolic syndrome as well as gallstone formation.


  • Gene structure of human cholecystokinin (CCK) type‐A receptor: body fat content is related to CCK type‐A receptor gene promoter polymorphism

    by Akihiro Funakoshi, Kyoko Miyasaka, Hideo Matsumoto, Shunji Yamamori, Sohichi Takiguchi, Kazuhiro Kataoka, Yutaka Takata, Kimihiko Matsusue, Akira Kono, Hiroshi Shimokata

    The transcriptional start site of the human cholecystokinin (CCK)‐A receptor gene was determined by the Capsite Hunting method. Two sequence changes were detected, a G to T change in nucleotide −128, and an A to G change in nucleotide −81. The homozygote (T/T, G/G) was detected in 25 of 1296 individuals (1.9%) in the cohort study. This polymorphism showed a significantly higher percent body fat and higher levels of serum insulin and leptin, compared with wild type and heterozygotes. Our study provided the possibility that polymorphism in the promoter region of the CCK‐A receptor gene may be one of genetic factors affecting fat deposition.


  • Mechanism of Cholecystokinin-A- Receptor Antagonist on Human Pancreatic Exocrine Secretion

    by Akihiro Funakoshi, Yuji Fukamizu, Kyoko Miyasaka

    Expressions of the cholecystokinin (CCK)-A and -B receptor genes in human duodenum, pancreas and gallbladder were examined by Northern blot analysis and reverse transcriptase polymerase chain reaction (RT-PCR) followed by Southern blot hybridization. The autoradiographic study of CCK-A and -B receptors in the human duodenum and pancreas was examined in vitro. To determine the subtypes to CCK receptors in the pancreas or duodenum, we studied the abilities of CCK-A and -B receptor agonists (CCK-8 and gastrin) and antagonists (loxiglumide, L-364,718 and L-365,260) to inhibit binding of 125I-CCK-8. CCK-A receptor mRNA was not expressed in the human pancreas, but was expressed in the gallbladder and duodenum, although it was expressed in the pancreas by RT-PCR. CCK-B receptor mRNA was expressed in the pancreas, but not in gallbladder and duodenum. Using autoradiography, high concentrations of CCK-A receptors were detected in the duodenal mucosa, although in the pancreas only CCK-B receptors were detected by this method. These results suggest that localization of CCK-A receptor in human duodenum provides a biochemical and morphological basis for some physiological functions of CCK.